Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,276,767 papers from all fields of science
Search
Sign In
Create Free Account
OPC 4392
Known as:
2(1H)-Quinolinone, 7-(3-(4-(2,3-dimethylphenyl)-1-piperazinyl)propoxy)-
, OPC-4392
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Piperazines
Quinolones
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Partial agonists in schizophrenia--why some work and others do not: insights from preclinical animal models.
S. Natesan
,
G. Reckless
,
Karen B. L. Barlow
,
J. Nobrega
,
S. Kapur
International Journal of Neuropsychopharmacology
2011
Corpus ID: 14074277
While dopamine D2 receptor partial agonists (PAs) have been long considered for treating schizophrenia, only one, aripiprazole…
Expand
Highly Cited
2008
Highly Cited
2008
Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors.
Y. Tadori
,
R. Forbes
,
R. Mcquade
,
T. Kikuchi
European Journal of Pharmacology
2008
Corpus ID: 22624545
2007
2007
Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling
S. Jordan
,
Janelle L. Johnson
,
+6 authors
T. Kikuchi
Progress in Neuro-psychopharmacology and…
2007
Corpus ID: 30891015
Highly Cited
2005
Highly Cited
2005
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
Y. Tadori
,
T. Miwa
,
+4 authors
T. Kikuchi
European Journal of Pharmacology
2005
Corpus ID: 38170887
2005
2005
Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients
F. Duval
,
M. Mokrani
,
+4 authors
X. Lataste
Psychopharmacology
2005
Corpus ID: 21060835
The aim of this study was to evaluate the effect on the activity of the hypothalamic-pituitary dopaminergic system of two new…
Expand
1996
1996
Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats
M. Fujikawa
,
M. Nagashima
,
Tsutomu Inoue
,
Katsushi Yamada
,
T. Furukawa
Pharmacology, Biochemistry and Behavior
1996
Corpus ID: 25203631
Highly Cited
1995
Highly Cited
1995
7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and…
T. Kikuchi
,
K. Tottori
,
+5 authors
S. Morita
Journal of Pharmacology and Experimental…
1995
Corpus ID: 41799571
1988
1988
The Effect of OPC-4392, a Partial Dopamine Receptor Agonist on Negative Symptoms: Results of an Open Study
H. Gerbaldo
,
L. Demisch
,
Lehmann Co
,
J. Bochnik
Pharmacopsychiatry
1988
Corpus ID: 27908337
OPC4392 (7 -3-[4-(2,3-dimethylphenyl)piperazinyl]-propoxy-2(1 H)-quinolinone) belongs to a new dass of compounds aeting as…
Expand
1988
1988
Studies on 2(1H)-quinolinone derivatives as neuroleptic agents I. Synthesis and biological activities of (4-phenyl-1-piperazinyl)-propoxy-2(1H)-quinolinone derivatives.
K. Banno
,
T. Fujioka
,
T. Kikuchi
,
Y. Oshiro
,
T. Hiyama
,
K. Nakagawa
Chemical and pharmaceutical bulletin
1988
Corpus ID: 30980061
With the aim of developing a novel neuroleptic drug, a series of ω-(4-phenyl-1-piperazinyl)-alkoxy-2 (1H)-quinolinone derivatives…
Expand
1988
1988
7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
Y. Yasuda
,
T. Kikuchi
,
S. Suzuki
,
M. Tsutsui
,
K. Yamada
,
T. Hiyama
Life Science
1988
Corpus ID: 23863593
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE